Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
BMC Public Health
Published in: BMC Public Health 1/2015

Open Access 01-12-2015 | Research article

Non-adherence to anti-tuberculosis treatment among internal migrants with pulmonary tuberculosis in Shenzhen, China: a cross-sectional study

Authors: Ying Tang, Meigui Zhao, Yunxia Wang, Yanhong Gong, Xiaoxv Yin, Angui Zhao, Juanjuan Zheng, Zhenyang Liu, Xiaofang Jian, Wenxin Wang, Chunmei Wu, Zuxun Lu

Published in: BMC Public Health | Issue 1/2015

Login to get access

Abstract

Background

Non-adherence to tuberculosis (TB) treatment threatens the success of treatment, increases the risk of TB spread, and leads to the development of drug resistance. The present study assessed non-adherence to anti-TB treatment among internal migrants with pulmonary TB living in Shenzhen, China, and examined risk factors for non-adherence in order to identify targets for intervention.

Methods

A total of 794 internal migrants with TB treated at Bao’an Hospital for Chronic Disease Prevention and Cure, Shenzhen, were recruited. Structured questionnaires were used to collect data on these patients’ history and experiences with TB treatment. Ordinal logistic regression model were used to identify risk factors for non-adherence.

Results

The proportion of patients who had missed one dose of medication within two weeks was 93/794 (11.71%), and those who missed at least two doses of medication within two weeks was 167/794 (21.03%), with a total of 33.74% of patients not adhering to TB treatment. Lack of knowledge about TB treatment and longer travel time to the nearest community health centers are significant predictors for non-adherence.

Conclusions

The present study shows that non-adherence is common among internal migrants with TB. Patients who lack knowledge about TB treatment or have to travel far to get treated are prone to miss one or more doses of medication. Interventions to improve health education and healthcare access are essential to reduce non-adherence to TB treatment among internal migrants.
Literature
1.
World Health Organization. Global tuberculosis report 2013. Genava: WHO Press; 2014.
2.
National Technical Steering Group of the Epidemiological Sampling Survey for Tuberculosis. The Fifth National Tuberculosis Epidemiological Survey in 2010. Chin J Anti-tubrculosis. 2012;34:485–508.
3.
4.
Chaulk CP, Kazandjian VA. Directly observed therapy for treatment completion of pulmonary tuberculosis: Consensus Statement of the Public Health Tuberculosis Guidelines Panel. JAMA. 1998;279:943–8.CrossRefPubMed
5.
Zhang LX, Tu DH, An YS, Enarson DA. The impact of migrants on the epidemiology of tuberculosis in Beijing, China. Int J Tuberc Lung Dis. 2006;10:959–62.PubMed
6.
Li T, He XX, Chang ZR, Ren YH, Zhou JY, Ju LR, et al. Impact of new migrant populations on the spatial distribution of tuberculosis in Beijing. Int J Tuberc Lung Dis. 2011;15:163–8.PubMed
7.
National Health and Family Planning Commission of the People’s Republic of China. Report on China’s migrant population development (2013). Beijing: China Population Publishing House; 2013.
8.
Wang L, Liu J, Chin DP. Progress in tuberculosis control and the evolving public-health system in China. Lancet. 2007;369:691–6.CrossRefPubMed
9.
Bureau of Statistics of the Shenzhen Municipality. The Shenzhen statistics yearbook 2013. Shenzhen: China Statistics Press; 2013.
10.
Xiao SY. Theory basis and application of the social support rating scale. J Clin Psychiatry. 1994;4:98–100.
11.
Lin QH, Jiang CQ, Lam TH. The relationship between occupational stress, burnout, and turnover intention among managerial staff from a Sino-Japanese joint venture in Guangzhou, China. J Occup Health. 2013;55:458–67.CrossRefPubMed
12.
Xu J, Wei Y. Social support as a moderator of the relationship between anxiety and depression: an empirical study with adult survivors of Wenchuan earthquake. PloS one. 2013;8, e79045.CrossRefPubMedPubMedCentral
13.
Zhou C, Chu J, Liu J, Gai Tobe R, Gen H, Wang X, et al. Adherence to tuberculosis treatment among migrant pulmonary tuberculosis patients in Shandong, China: a quantitative survey study. PloS one. 2012;7, e52334.CrossRefPubMedPubMedCentral
14.
Hu D, Liu X, Chen J, Wang Y, Wang T, Zeng W, et al. Direct observation and adherence to tuberculosis treatment in Chongqing, China: a descriptive study. Health Policy Plan. 2008;23:43–55.CrossRefPubMed
15.
Yao S, Huang WH, van den Hof S, Yang SM, Wang XL, Chen W, et al. Treatment adherence among sputum smear-positive pulmonary tuberculosis patients in mountainous areas in China. BMC Health Serv Res. 2011;11:341.CrossRefPubMedPubMedCentral
16.
Xu W, Lu W, Zhou Y, Zhu L, Shen H, Wang J. Adherence to anti-tuberculosis treatment among pulmonary tuberculosis patients: a qualitative and quantitative study. BMC Health Serv Res. 2009;9:169.CrossRefPubMedPubMedCentral
17.
Frieden T. What is intermittent treatment and what is the scientific basis for intermittency. In: Frieden T, editor. Toman's tuberculosis case detection, treatment, and mmonitoring. 2nd ed. Geneva: World Health Organization; 2004. p. 130–8.
18.
Driver CR, Matus SP, Bayuga S, Winters AI, Munsiff SS. Factors associated with tuberculosis treatment interruption in New York City. J Public Health Manag Pract. 2005;11:361–8.CrossRefPubMed
19.
Thiam S, LeFevre AM, Hane F, Ndiaye A, Ba F, Fielding KL, et al. Effectiveness of a strategy to improve adherence to tuberculosis treatment in a resource-poor setting: a cluster randomized controlled trial. JAMA. 2007;297:380–6.CrossRefPubMed
20.
Liam CK, Lim KH, Wong CM, Tang BG. Attitudes and knowledge of newly diagnosed tuberculosis patients regarding the disease, and factors affecting treatment compliance. Int J Tuberc Lung Dis. 1999;3:300–9.PubMed
21.
Menzies R, Rocher I, Vissandjee B. Factors associated with compliance in treatment of tuberculosis. Tuber lung dis. 1993;74:32–7.CrossRefPubMed
22.
Mishra P, Hansen EH, Sabroe S, Kafle KK. Socio-economic status and adherence to tuberculosis treatment: a case–control study in a district of Nepal. Int J Tuberc Lung Dis. 2005;9:1134–9.PubMed
Metadata
Title
Non-adherence to anti-tuberculosis treatment among internal migrants with pulmonary tuberculosis in Shenzhen, China: a cross-sectional study
Authors
Ying Tang
Meigui Zhao
Yunxia Wang
Yanhong Gong
Xiaoxv Yin
Angui Zhao
Juanjuan Zheng
Zhenyang Liu
Xiaofang Jian
Wenxin Wang
Chunmei Wu
Zuxun Lu
Publication date
01-12-2015
Publisher
BioMed Central
Published in
BMC Public Health / Issue 1/2015
Electronic ISSN: 1471-2458
DOI
https://doi.org/10.1186/s12889-015-1789-z

Other articles of this Issue 1/2015

BMC Public Health 1/2015 Go to the issue

Research article

Impact evaluation of a community-based intervention to reduce risky sexual behaviour among female sex workers in Shanghai, China

Research article

Vaccine coverage and determinants of incomplete vaccination in children aged 12–23 months in Dschang, West Region, Cameroon: a cross-sectional survey during a polio outbreak

Research article

An objective assessment of toddlers’ physical activity and sedentary levels: a cross-sectional study

Study protocol

Physical activity promotion in the primary care setting in pre- and type 2 diabetes - the Sophia step study, an RCT

Research article

Pilot to evaluate the feasibility of measuring seasonal influenza vaccine effectiveness using surveillance platforms in Central-America, 2012

Erratum

Erratum to: A novel antigen capture ELISA for the specific detection of IgG antibodies to elephant endotheliotropic herpes virus